Conclusion The platelet-rich plasmas failed to demonstrate significant benefits that justify the daily use, and the use of platelet-rich fibrin is limited to some very specific applications in which satisfactory results were achieved. Only a new simple, inexpensive and efficient technique such as the leucocyteand platelet-rich fibrin will continue to develop in oral and maxillofacial surgery in the next years.
No takes yet. Share an insight, caveat, or question.
Lauritano et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: